Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer

American Journal of Roentgenology

Volumn 198, Issue 1, 2012, Pages 219-232

  Berg, Wendie A ^a,b   Madsen, Kathleen S ^c   Schilling, Kathy ^d   Tartar, Marie ^e   Pisano, Etta D ^f,g   Larsen, Linda Hovanessian ^h   Narayanan, Deepa ^i,j   Kalinyak, Judith E ⁱ  

^a Johns Hopkins Green Spring   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Certus International   (United States)

^d BOCA RATON REGIONAL HOSPITAL   (United States)

^e SCRIPPS CLINIC   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ Naviscan Inc   (United States)

^j NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

Breast cancer; Contralateral breast; MRI; Positron emission mammography; Synchronous bilateral breast cancer; Treatment planning

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION MAMMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84455209446     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.6342     Document Type: Article

References (69)

1. Kelmendi de Ustarán J, Meiss RP. Primary synchronous bilateral breast cancer: epidemiological approach. Breast Cancer Res Treat 1988; 12:311-314
2. Heron DE, Komarnicky LT, Hyslop T, Schwartz GF, Mansfield CM. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 2000; 88:2739-2750 (Pubitemid 30417934)
3. Irvine T, Allen DS, Gillett C, Hamed H, Fentiman IS. Prognosis of synchronous bilateral breast cancer. Br J Surg 2009; 96:376-380
4. Kheirelseid EA, Jumustafa H, Miller N, et al. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics. Breast Cancer Res Treat 2011; 126:131-140
5. Polednak AP. Bilateral synchronous breast cancer: a population-based study of characteristics, method of detection, and survival. Surgery 2003; 133:383-389 (Pubitemid 36515326)
6. Carmichael AR, Bendall S, Lockerbie L, Prescott R, Bates T. The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours. Eur J Surg Oncol 2002; 28:388-391
7. Verkooijen HM, Chatelain V, Fioretta G, et al. Survival after bilateral breast cancer: results from a population-based study. Breast Cancer Res Treat 2007; 105:347-357 (Pubitemid 47596444)
8. Beinart G, Gonzalez-Angulo AM, Broglio K, et al. Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival. Clin Breast Cancer 2007; 7:867-874
9. Lesser ML, Rosen PP, Kinne DW. Multicentricity and bilaterality in invasive breast carcinoma. Surgery 1982; 91:234-240 (Pubitemid 12168596)
10. National Comprehensive Cancer Network Website. NNCN clinical practice guidelines in oncology: genetic/familial high-risk assessments - breast and ovarian. www.nccn.org/professionals/physician-gls/PDF/genetics-screening.pdf. Accessed November 2, 2011
11. Hartman M, Czene K, Reilly M, et al. Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol 2007; 25:4210-4216 (Pubitemid 47548560)
12. Takahashi H, Watanabe K, Takahashi M, Taguchi K, Sasaki F, Todo S. The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer. Breast Cancer 2005; 12:196-202
13. Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004; 233: 830-849
14. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999; 213:881-888
15. Lehman CD, Blume JD, Thickman D, et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol 2005; 92:9-15; discussion, 15-16
16. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007; 356:1295-1303 (Pubitemid 46513295)
17. Liberman L, Morris EA, Kim CM, et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR 2003; 180:333-341 (Pubitemid 36135009)
18. Rieber A, Merkle E, Bohm W, Brambs HJ, Tomczak R. MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 1997; 21:773-779 (Pubitemid 28049627)
19. Lee SG, Orel SG, Woo IJ, et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 2003; 226:773-778 (Pubitemid 36259154)
20. Bernard JR Jr, Vallow LA, DePeri ER, et al. Newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women: the Mayo Clinic in Florida experience. Breast J 2010; 16: 118-126
21. Moon WK, Noh DY, Im JG. Multifocal, multicentric, and contralateral breast cancers: bilateral whole-breast US in the preoperative evaluation of patients. Radiology 2002; 224:569-576 (Pubitemid 34809143)
22. Ozaki S, Tozaki M, Fukuma E, et al. Bilateral breast MR imaging: is it superior to conventional methods for the detection of contralateral breast cancer? Breast Cancer 2008; 15:169-174
23. Kim MJ, Kim EK, Kwak JY, Park BW, Kim SI, Oh KK. Bilateral synchronous breast cancer in an Asian population: mammographic and sonographic characteristics, detection methods, and staging. AJR 2008; 190:208-213
24. Berg WA, Blume JD, Adams AM, et al. Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology 2010; 254:79-87
25. MacDonald L, Edwards J, Lewellen T, Haseley D, Rogers J, Kinahan P. Clinical imaging characteristics of the positron emission mammography camera: PEM Flex Solo II. J Nucl Med 2009; 50:1666-1675
26. Thompson CJ, Murthy K, Weinberg IN, Mako F. Feasibility study for positron emission mammography. Med Phys 1994; 21:529-538 (Pubitemid 24129931)
27. Berg WA, Madsen KS, Schilling K, et al. Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. Radiology 2011; 258:59-72
28. Berg WA, Weinberg IN, Narayanan D, et al. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J 2006; 12:309-323 (Pubitemid 43989975)
29. Schilling K, Narayanan D, Kalinyak JE, et al. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging. Eur J Nucl Med Mol Imaging 2011; 38:23-36
30. Narayanan D, Madsen KS, Kalinyak JE, Berg WA. Interpretation of positron emission mammography and MRI by experienced breast imaging radiologists: performance and observer reproducibility. AJR 2011; 196:971-981
31. D'Orsi CJ, Bassett LW, Berg WA, et al. BI-RADS: mammography, 4th ed. In: D'Orsi CJ, Mendelson EB, Ikeda DM, et al. Breast Imaging Reporting and Data System: ACR BI-RADS - breast imaging atlas. Reston, VA: American College of Radiology, 2003
32. Mendelson EB, Baum JK, Berg WA, et al. BI-RADS: ultrasound. In: D'Orsi CJ, Mendelson EB, Ikeda DM, et al. Breast Imaging Reporting and Data System: ACR BI-RADS - breast imaging atlas. Reston, VA: American College of Radiology, 2003
33. Ikeda DM, Hylton NM, Kuhl CK, et al. BI-RADS: magnetic resonance imaging. In: D'Orsi CJ, Mendelson EB, Ikeda DM, et al. Breast Imaging Reporting and Data System: ACR BI-RADS - breast imaging atlas. Reston, VA: American College of Radiology, 2003
34. Narayanan D, Madsen KS, Kalinyak JE, Berg WA. Interpretation of positron emission mammography: feature analysis and rates of malignancy. AJR 2011; 196:956-970
35. Kalinyak JE, Schilling K, Berg WA, et al. PET-guided breast biopsy. Breast J 2011; 17:143-151
36. Pepe MS. The statistical evaluation of medical tests for classification and prediction. New York, NY: Oxford University Press, 2003
37. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42:121-130
38. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44:837-845
39. Dorfman DD, Berbaum KS, Metz CE. Receiver operating characteristic rating analysis: generalization to the population of readers and patients with the jackknife method. Invest Radiol 1992; 27:723-731
40. Brennan ME, Houssami N, Lord S, et al. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol 2009; 27: 5640-5649
41. Varas X, Leborgne JH, Leborgne F, Mezzera J, Jaumandreu S. Revisiting the mammographic follow-up of BI-RADS category 3 lesions. AJR 2002; 179:691-695 (Pubitemid 34919583)
42. Vizcaino I, Gadea L, Andreo L, et al. Short-term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography. Radiology 2001; 219:475-483 (Pubitemid 32336365)
43. Eby PR, DeMartini WB, Gutierrez RL, Saini MH, Peacock S, Lehman CD. Characteristics of probably benign breast MRI lesions. AJR 2009; 193:861-867
44. Sickles EA. Management of probably benign lesions of the breast. Radiology 1994; 193:582-583 (Pubitemid 24338358)
45. Chala L, Endo E, Kim S, et al. Gray-scale sonography of solid breast masses: diagnosis of probably benign masses and reduction of the number of biopsies. J Clin Ultrasound 2007; 35:9-19 (Pubitemid 46106451)
46. Graf O, Helbich TH, Hopf G, Graf C, Sickles EA. Probably benign breast masses at US: is follow-up an acceptable alternative to biopsy? Radiology 2007; 244:87-93 (Pubitemid 46981961)
47. Metz CE. ROC methodology in radiologic imaging. Invest Radiol 1986; 21:720-733 (Pubitemid 16015664)
48. Sickles EA. Findings at mammographic screening on only one standard projection: outcomes analysis. Radiology 1998; 208:471-475 (Pubitemid 28373757)
49. Rafferty EA, Niklason LT, Jameson-Meehan LA. Breast tomosynthesis: one view or two? (abstr) In: Radiological Society of North America. Oak Brook, IL: RSNA, 2006:335
50. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011; 305:569-575
51. Morrow M. Magnetic resonance imaging in the breast cancer patient: curb your enthusiasm. J Clin Oncol 2008; 26:352-353 (Pubitemid 351171683)
52. Solin LJ, Orel SG, Hwang WT, Harris EE, Schnall MD. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008; 26:386-391 (Pubitemid 351171689)
53. Li J, Patil S, VanZee K, Liberman L, Dershaw DD, Morris EA. Preoperative breast MRI: outcomes in early stage breast cancer. (abstr) In: Radiological Society of North America. Oak Brook, IL, 2010
54. Broet P, de la Rochefordiere A, Scholl SM, et al. Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol 1995; 13:1578-1583
55. Alkner S, Bendahl PO, Ferno M, Nordenskjold B, Ryden L. Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: results from a controlled randomised trial. Eur J Cancer 2009; 45:2496-2502
56. Cuzick J, Sestak I, Baum M, et al.; ATAC/LATTE Investigators. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 2010; 11:1135-1141
57. Rosen PP, Groshen S, Kinne DW, Hellman S. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery 1989; 106:904-910 (Pubitemid 19283388)
58. Chaudary MA, Millis RR, Hoskins EO, et al. Bilateral primary breast cancer: a prospective study of disease incidence. Br J Surg 1984; 71:711-714 (Pubitemid 14066682)
59. Chaudary MA, Millis RR, Bulbrook RD, Hayward JL. Family history and bilateral primary breast cancer. Breast Cancer Res Treat 1985; 5: 201-205 (Pubitemid 15124780)
60. Brennan S, Liberman L, Dershaw DD, Morris E. Breast MRI screening of women with a personal history of breast cancer. AJR 2010; 195:510-516
61. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57:75-89 (Pubitemid 46535708)
62. Hendrick RE. Radiation doses and cancer risks from breast imaging studies. Radiology 2010; 257:246-253
63. Sorbero ME, Dick AW, Beckjord EB, Ahrendt G. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol 2009; 16:1597-1605
64. Roubidoux MA, Helvie MA, Wilson TE, Lai NE, Paramagul C. Women with breast cancer: histologic findings in the contralateral breast. Radiology 1997; 203:691-694 (Pubitemid 27227416)
65. Slanetz PJ, Edmister WB, Yeh ED, Talele AC, Kopans DB. Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J 2002; 8:145-148 (Pubitemid 34627771)
66. Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclicalphase dependency. Radiology 1997; 203:137-144 (Pubitemid 27142721)
67. Zytoon AA, Murakami K, El-Kholy MR, El-Shorbagy E, Ebied O. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT. Eur J Radiol 2009; 70:530-538
68. Eby PR, Demartini WB, Peacock S, Rosen EL, Lauro B, Lehman CD. Cancer yield of probably benign breast MR examinations. J Magn Reson Imaging 2007; 26:950-955 (Pubitemid 47548155)
69. Weinstein SP, Hanna LG, Gatsonis C, Schnall MD, Rosen MA, Lehman CD. Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667. Radiology 2010; 255:731-737